TR
Trevena, Inc.
TRVN · OTC
$0.01 +0.00% (+$0.00)
1M +1,020.00%
Market Cap $9.67K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.00x
P/E N/A
EV/EBITDA N/A
Growth
23 /100
Declining Rev. growth 0.60%
EPS growth N/A
FCF growth N/A
Profitability
19 /100
Weak Gross margin 46.56%
Net margin 1,289.25%
Op. margin 1,129.22%
Quality
1 /100
Poor ROIC 104.42%
ROA 99.22%
Asset turnover 0.08x
Debt
100 /100
Low Current ratio 4.66x
Debt/Equity N/A
Int. coverage N/A
Stability
25 /100
Unstable Beta -0.41x
Rev. volatility 564.93%
EPS volatility 48.03%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TRVN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Carrie L. Bourdow
Employees
23
Headquarters
Chesterbrook
Upcoming events
05 NOV
Earnings
Upcoming earnings report